TARGETING BTN2A1 MODULATES ANTI-TUMOR ACTIVITY OF VG9VD2 T CELLS

被引：0

作者：

Cano, Carla ^{[1
]}

de Gassart, Aude ^{[1
]}

Pasero, Christine ^{[1
]}

Gabriac, Melanie ^{[1
]}

Fullana, Marie ^{[1
]}

Granarolo, Emilie ^{[1
]}

Hoet Rene ^{[1
]}

Imbert, Caroline ^{[1
]}

Gorvel, Laurent ^{[2
]}

Briantais, Antoine ^{[2
]}

Le Floch, Anne-Charlotte ^{[2
]}

Olive, Daniel ^{[2
]}

机构：

[1] ImCheck Therapeut, Marseille, France

[2] CRCM, Marseille, France

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷

关键词：

D O I：

10.1136/jitc-2020-SITC2020.0211

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

211

引用

页码：A126 / A127

页数：2

共 50 条

[21] Targeting BTN2A1 By a Unique Activating Mab Improves Vγ9Vδ2 T Cell Cytotoxicity Against Primary Acute Lymphoblastic Blasts
Le Floch, Anne-Charlotte
Imbert, Caroline
De Gassart, Aude
Orlanducci, Florence
Le Roy, Aude
Gorvel, Laurent
Vey, Norbert
Briantais, Antoine
Boucherit, Nicolas
Cano, Carla E.
Olive, Daniel
BLOOD, 2021, 138
[22] Human Vγ9Vδ2 T cells exert anti-tumor activity independently of PD-L1 expression in tumor cells
Tomogane, Mako
Sano, Yusuke
Shimizu, Daiki
Shimizu, Teruki
Miyashita, Masatsugu
Toda, Yuki
Hosogi, Shigekuni
Tanaka, Yoshimasa
Kimura, Shinya
Ashihara, Eishi
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 573 : 132 - 139
[23] Loss and recovery of Vg2Vd2 T cells in HIV/AIDS
Propp, Nadia
Cairo, Cristiana
Hebbeler, Andrew
Deetz, Carl
Cummings, Jean-Saville
Pauza, C. David
RETROVIROLOGY, 2005, 2 (Suppl 1)
[24] Loss and Recovery of Vg2Vd2 T cells in HIV/AIDS
Nadia Propp
Cristiana Cairo
Andrew Hebbeler
Carl Deetz
Jean-Saville Cummings
C David Pauza
Retrovirology, 2
[25] POTENTIAL ANTI-TUMOR AGENTS .9. SYNTHESIS AND ANTI-TUMOR ACTIVITY OF 2 ANALOGS OF KETOCAINE
ANDREANI, A
SCAPINI, G
GALATULAS, I
BOSSA, R
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (07) : 814 - 815
[26] BTN2A1 targeting reprograms M2-like macrophages and TAMs via SYK and MAPK signaling
Kerneur, Clement
Foucher, Etienne
Casas, Jaime Guillen
Colazet, Magali
Le, Kieu-Suong
Fullana, Marie
Bergot, Elise
Audemard, Corentin
Drapeau, Marion
Louche, Pauline
Gorvel, Laurent
Rouviere, Marie-Sarah
Boucherit, Nicolas
Audebert, Stephane
Magrini, Elena
Carnevale, Silvia
de Gassart, Aude
Madakamutil, Loui
Mantovani, Alberto
Garlanda, Cecilia
Agaugue, Sophie
Cano, Carla E.
Olive, Daniel
CELL REPORTS, 2024, 43 (10):
[27] Colorectal cancer microenvironment expressing BTN3A1 stimulate effector γδ T cells with anti-tumor activity upon zoledronate treatment
Zocchi, M. R.
Costa, D.
Vene, R.
Tosetti, F.
Ferrari, N.
Minghelli, S.
Benelli, R.
Scabini, S.
Romairone, E.
Catellani, S.
Profumo, A.
Poggi, A.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 140 - 140
[28] CORRELATION OF BASELINE CIRCULATING VG9VD2 T CELL COUNTS AND PHARMACODYNAMIC ACTIVITY OF ICT01 IN CANCER PATIENTS: PRELIMINARY RESULTS FROM EVICTION AND A NOVEL PATIENT ENRICHMENT STRATEGY
Valentin, Emmanuel
de Gassart, Aude
Brune, Patrick
Ghigo, Clement
Agaugue, Sophie
Olive, Daniel
Frohna, Paul
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A558 - A558
[29] MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity
Zhai, Xiaochen
You, Fengtao
Xiang, Shufen
Jiang, Licui
Chen, Dan
Li, Yafen
Fan, Shuangshuang
Han, Zhichao
Zhang, Tingting
An, Gangli
Zhang, Bozhen
Chen, Yusheng
Meng, Huimin
Yang, Lin
AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (01): : 79 - 91
[30] DEVELOPMENT OF A MOLECULAR TARGETED CYTOKINE THAT SPECIFICALLY EXPANDS VGAMMA9VDELTA2 T CELLS AND POTENTIATES ANTI-TUMOR ACTIVITY
Becklund, Bryan
Robinson, Kaitlyn
Jones, Kyle
Sanabria, Angelica
Torretti, Elisebeth
Eckles, Andrew
Hussain, Abrahim
Ahn, Sae Jeong
Pandit, Rajay
Sulzmaier, Florian
Timmer, John
Eckelman, Brendan
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1119 - A1119

← 1 2 3 4 5 →